A 3 Month, Randomised, Open Label, Parallel Group, Descriptive Study to Explore and Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept (Etanercept Auto-Injector and the Etanercept Prefilled Syringe) in Patients With Psoriasis.
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2012
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors Wyeth Pharmaceuticals
- 01 Apr 2012 Results published in the Journal of the European Academy of Dermatology and Venereology.
- 29 Mar 2012 Actual patient number is 421 according to ClinicalTrials.gov.
- 09 Jun 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.